CYBERDYNE Inc. (7779.T)
- Previous Close
208.00 - Open
205.00 - Bid 202.00 x --
- Ask 202.00 x --
- Day's Range
200.00 - 207.00 - 52 Week Range
188.00 - 357.00 - Volume
466,800 - Avg. Volume
963,829 - Market Cap (intraday)
42.86B - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
-- - EPS (TTM)
-6.22 - Earnings Date May 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
320.00
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high-speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance and regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; Neuro HALFIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT at home for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants, as well as entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.
www.cyberdyne.jpRelated News
Performance Overview: 7779.T
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7779.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7779.T
Valuation Measures
Market Cap
42.86B
Enterprise Value
26.75B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.40
Price/Book (mrq)
1.04
Enterprise Value/Revenue
6.47
Enterprise Value/EBITDA
88.26
Financial Highlights
Profitability and Income Statement
Profit Margin
-31.86%
Return on Assets (ttm)
-2.58%
Return on Equity (ttm)
-3.48%
Revenue (ttm)
4.13B
Net Income Avi to Common (ttm)
-1.32B
Diluted EPS (ttm)
-6.22
Balance Sheet and Cash Flow
Total Cash (mrq)
16.74B
Total Debt/Equity (mrq)
1.53%
Levered Free Cash Flow (ttm)
-1.3B
Research Analysis: 7779.T
Company Insights: 7779.T
7779.T does not have Company Insights